COVID-19 Vaccines for Preschoolers
Where’s the evidence?
7 min readFeb 4, 2022
On 2021–12–17, Pfizer announced that initial results from its clinical study evaluating two doses of its COVID-19 vaccine for children under five showed that high efficacy was demonstrated only in the six to 24 month population, but not among those two to five years of age.
